:
Skip to main content
HHS.gov
Menu
Main navigation
CDS Home
Overview
CDS Connect
CDS Innovation Collaborative
CEDAR
Evaluation
Funding Opportunities
Resources
Contact Us
CDS Connect Global
Welcome
About
Governance
Repository
Authoring Tool
Community
FAQ
Repository User Guide
An official website of the Department of Health & Human Services
Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
Patient-Centered Outcomes Research
Clinical Decision Support
Accelerating Evidence into Practice through CDS
Search
Enter the terms you wish to search for.
Authoring Tool
CDS Connect Login
Main navigation
CDS Home
Overview
CDS Connect
CDS Innovation Collaborative
CEDAR
Evaluation
Funding Opportunities
Resources
Contact Us
CDS Connect Global
Welcome
About
Governance
Repository
Authoring Tool
Community
FAQ
Repository User Guide
Welcome
license
Federal Government Unlimited Rights License
Federal Government Unlimited Rights License
Jul 30 2021
Preferred therapy recommendation for adult asthmatic Step 4 to 5 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for child Step 4 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult Step 4 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for asthmatic Step 3-to-4 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for Step 3 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for asthmatic Step 2-to-3 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult Step 2 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult asthmatic Step 1-to-2 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Nov 30 2020
Managing chronic pain with Prescription Drug Monitoring Program (PDMP) medication dispense data
Artifact Type
Data Summary
Publisher
TISTA Science and Technology Corporation
Analgesics, Opioid
Opioid-Related Disorders
Pain Management
Created:
2020-11-17
Updated:
2020-11-30
Jul 13 2020
Screening and Interventions for Unhealthy Alcohol Use: Logic for Best Practice Alerts
Artifact Type
Alert
Publisher
RTI-UNC Evidence-based Practice Center
Alcohol Drinking
Primary Health Care
Internal Medicine
Created:
2018-10-31
Reviewed:
2020-07-13
Updated:
2018-12-27
Pagination
Next page
››